Running MEDDPICC in a deal review

What a deal review actually is

A deal review is a stress test, not a status update. A VP is establishing two things: whether the deal is real, and whether you can be relied on to tell the difference. The second matters more — it determines how much of your forecast they believe all year.

Expect the grilling to be uncomfortable and impersonal. Good leaders push hardest on the letters you are least sure about, because that is where the information is. Reps who take it personally spend the review defending; the rest think.

Voice from the field

"You'll want to meet with the Champion for each of the forecasted deals to ensure your rep has a Champion and is in control."
— John McMahon, The Qualified Sales Leader (2021)

The "how do you know?" ladder

Almost every hard question in a deal review reduces to one word: evidence. Answer on three rungs, and always volunteer the highest you legitimately have.

• Rung one — assertion. "They're on board." Worthless; invites the follow-up.
• Rung two — source. "The QA lead told me the COO signs above £250k." Better; still one person's word.
• Rung three — artefact or event. "I met the COO on the 14th; she asked for the validation pack before contract and named the 3 September board date; it's in the mutual action plan she countersigned." Unassailable.

The answer that earns the most respect is a precise red. "I don't know, and here's how I'll find out by Friday" outperforms a confident amber every time, because it tells your VP their forecast can be trusted.

The questions that expose weak qualification

These recur across almost every enterprise sales organisation. Have an answer to each at rung three where possible.

• Who signs this, and when did you last speak to them?
• Whose numbers are in the business case — yours or theirs?
• Who wrote the criteria, and which one did we put in there?
• What are the exact dates of the next two gates, and the papers deadlines?
• What has your champion done for us that cost them something, and if they left tomorrow, who carries this?
• Who else is competing for this money — not just which vendors?
• What has to happen between "yes" and a purchase order, and who owns each step?
• If I called your champion tonight, what would they say the next step is?

That last question is the killer: it exposes the difference between a deal you are running and one you are watching. If your answer differs from what the customer would say, you have no mutual plan.

How to disqualify out loud without looking weak

Weak disqualification sounds like an excuse; strong disqualification sounds like a decision. The strong version leads with evidence, states a judgement, and reallocates the time.

The four-part form:

1. The evidence. "Two requests for economic-buyer access deflected without explanation, criteria briefed by the incumbent, no quantified pain."
2. The judgement. "I don't believe this is winnable this year."
3. The reallocation. "I'm moving the time onto Northbrook and two accounts in the same segment."
4. The trigger. "I'll re-engage if it reaches the trust risk register, or the incumbent contract comes up for renewal."

Never disqualify on a feeling, and never silently. Removing a deal without saying why looks like concealment; announcing it with evidence looks like judgement. Be honest about the organisational reality too: leaders praise disqualification in interviews more consistently than they reward it in a Monday pipeline review, so bring evidence and get your manager's agreement rather than acting alone.

Field note

The most useful preparation for a deal review is to run it on yourself the night before, out loud, in the harshest voice you can manage, writing down every question you cannot answer at rung three. Almost every rep finds the same thing: the letters they are shakiest on are the ones they have avoided asking the customer about, because the questions feel intrusive. Paper process and economic buyer top that list nearly every time. The discomfort of asking "who actually signs this, and what happens after they do?" is about two seconds long. Finding out in the last week of the quarter lasts a year.

7. Common misuse

MEDDPICC as a stage gate versus as a diagnostic

A stage gate says: you may not advance until every letter is green. It sounds rigorous and produces two pathologies: reps manufacture evidence to clear the gate, and good deals stall behind letters that cannot legitimately be answered yet — you cannot know a paper process before there is anything to paper.

A diagnostic says: here is what you don't know, so here is what to do next. The output is a work list, not a permission. Advancement should be driven by customer-verifiable events — a pilot agreed, a business case submitted, a decision communicated — with MEDDPICC describing the quality of the deal at that stage.

In interviews this is a differentiator. Anyone can recite eight letters. "We used it as a diagnostic, not a stage gate, because gating produces theatre" signals you have watched it used both ways.

The letter that is most often faked

Economic buyer, by a distance. It is easiest to fake because a name is easy to produce and hard to challenge, and because the honest answer ("I've never met them") is the most embarrassing thing a rep can say in a review.

The characteristic fakes: naming the most senior person on the org chart; counting an introductory call six months ago as access; accepting a champion's assurance; or quietly redefining the economic buyer downwards to whoever you have met. That last is the most dangerous: it is invisible in the CRM and reclassifies the deal as qualified when nothing has changed.

The test never changes: if this person says yes, does the money move? If it then goes to a committee or board, they are a recommender, and that committee is part of your decision or paper process.

The "we have a champion" delusion

The delusion has a shape: a friendly, responsive, senior-sounding contact who has never done anything costly for you. It persists because it is emotionally rewarding — calls are pleasant, replies fast, and confronting it risks a relationship that feels like the deal's main asset.

The cure is a behavioural audit, in writing. List everything this person has actually done — not said, done. Meetings arranged. Documents sent under their name. Bad news volunteered. If the list is short you have a coach or a cheerleader, and the deal needs a champion recruited elsewhere — work you can start today, far cheaper than discovering it in month nine.

When the framework is overkill

MEDDPICC is built for deals with several decision-makers, real money and a long cycle. On a transactional sale — single buyer, low price, two-week cycle — it is expensive ceremony. Nobody needs a paper-process analysis for a £4,000 subscription bought on a card.

A rough boundary: one or two buyers, a sub-month cycle and no committee means a lightweight filter — BANT or CHAMP, from module 3 — with the saved time spent on volume. Between the poles, most organisations run a reduced set: pain, economic buyer, competition and a date.

Saying so in an interview demonstrates judgement rather than doctrine. "MEDDPICC is right for their enterprise segment and overkill for their SMB motion" separates someone who has learned a framework from someone who has learned when to use it.

Two smaller misuses. Treating it as a discovery script — the letters are your checklist, not the customer's agenda. And scoring it alone: a private score drifts towards optimism invisibly, so it needs someone with authority to challenge it.